If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Pharmacy leaders warn against the online sale of weight-loss jabs, highlighting risks to patient safety and improper prescriptions for individuals with low body weight or prior eating disorders. The ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...

With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, successful year for Kenosha County. From fiscal wins to work on addressing ...

Mounjaro comes as a solution in a single-dose pen. You’ll administer Mounjaro weekly as a subcutaneous injection. You can take your dose with or without food. The drug’s manufacturer provides ...

Today we've published final guidance for the weight loss medication tirzepatide (mounjaro). It means the phased roll out – set out in our guidance – will begin in 2025. In 2022, the government ...

That would be bad news for Lilly, which makes competing GLP-1 drugs Zepbound and Mounjaro. For now, Medicare does not cover drugs prescribed specifically for weight loss, but it will cover GLP-1 ...

Mounjaro is administered as a pre-filled injection pen designed for easy self-injection. It can be injected under the skin of the stomach, thigh, or upper arm. The starting dose is 2.5mg once ...

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight ... watched blockbuster products — GLP-1 tirzepatide products Mounjaro and Zepbound — to miss consensus as well.